Latest Capital Management News

Credit Corp Group maintains its FY25 NPAT guidance amid operational gains in US debt buying and cautious optimism in Australian/New Zealand lending markets.

360 Capital Group has extended the closing date for its Off-Market Equal Access Buy-Back by one week to 21 May 2025, offering eligible securityholders additional time to participate. This adjustment also shifts key dates for payment and cancellation of securities.

SciDev Limited reported a robust Q3 FY25 with revenue rising 10% and EBITDA tripling, driven by strategic US market expansion and a landmark PFAS remediation contract despite ongoing market challenges.

Western Yilgarn Limited has successfully closed its non-renounceable Entitlement and Priority Option Offers, raising nearly A$54,000 through the issue of new options to shareholders.

Scentre Group reports rising customer visits and record business partner sales, while advancing major Westfield redevelopments and reaffirming 2025 earnings guidance.

TPG Telecom reported robust 2024 financials, expanded its mobile network coverage to 98.4% of Australians, and announced a strategic $5.25 billion fibre asset sale to Vocus Group, setting the stage for a leaner, more agile business in 2025.

Temple & Webster reports a strong trading update with revenue growth accelerating to 23% since March and a positive EBITDA margin outlook for FY25, despite ongoing economic headwinds.

Nine Entertainment reports solid Q3 advertising revenue growth and cost efficiencies while advancing a major stake sale in Domain, positioning the media giant for strategic expansion.

National Australia Bank (NAB) reported steady cash earnings and improved return on equity in the first half of 2025, underpinned by strong capital ratios and a clear strategic focus on business banking, deposits, and proprietary home lending.

National Australia Bank’s half year results to March 2025 reveal modest revenue growth and stable cash earnings amid competitive pressures and regulatory demands. The bank’s strong capital position and ongoing strategy execution underpin cautious optimism.

MyEco Group has secured $1.6 million through unsecured convertible notes to support a strategic operational restructure aimed at reducing costs and scaling production. This capital raise complements existing cash reserves and aims to improve margins while minimising shareholder dilution.

EZZ Life Science Holdings Limited has announced a fully franked ordinary dividend of AUD 0.02 per share for the six months ending December 2024, signaling steady returns for shareholders.